Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > TOP STORIES
TOP STORIES
-
ORGANIZATION Japan Govt Should Change Course on Consistent Price Cuts for On-Patent Drugs: FPMAJ Exec
March 22, 2021
-
BUSINESS Takeda’s OTC Unit to Be Renamed Alinamin with New Chief from Blackstone
March 22, 2021
-
REGULATORY MHLW to Set Up Medical Supply Office in April after COVID-19, Antibiotic Shortage
March 19, 2021
-
ORGANIZATION Trade Groups Push Proper Pricing of Innovative Drugs to Restore Attractiveness of Japan: LDP Confab
March 19, 2021
-
ORGANIZATION With Aducanumab in Mind, Outgoing Chuikyo Payer Rep Floats Rule to Reward Cost Cuts for Pricey Meds
March 18, 2021
-
BUSINESS Morimoto Pharma Looking to Partner with Drug Makers, CMOs to Develop Freeze-Dried COVID Vaccines in Japan
March 17, 2021
-
BUSINESS Quake-Halted Nipro Plant Affecting Supplies of Pfizer, Espha Generics
March 17, 2021
-
BUSINESS Alesion Dry Syrup, Generics Pulled from Shelves over Mutagenic Impurities
March 16, 2021
-
BUSINESS Takeda Appoints Milano Furuta as New Japan Chief
March 16, 2021
-
ACADEMIA Tokushukai Weighs Switches from Nichi-Iko Products after Biz Suspension Order
March 15, 2021
-
BUSINESS Me Pharma Eyes Production of 1 Billion Tablets in FY2021, Sales Buoyed by Low Prices
March 12, 2021
-
BUSINESS JMA Affiliate Data Operator Poised to Provide RWD from NHO Hospitals to Drug Makers
March 11, 2021
-
BUSINESS Takeda to Buy Out T-Cell Engager Specialist Maverick for US$525 Million
March 11, 2021
-
BUSINESS 70% of Major Products Fall Victim to Off-Year Drug Re-Pricing: Jiho Tally
March 10, 2021
-
BUSINESS Top-Tier Drug Makers Face 2-4% Cuts, Mid-Sized Firms 6-8% in Japan’s First Off-Year Re-Pricing: Tally
March 9, 2021
-
BUSINESS Top-3 Generic Makers Hit with Average 9.8% Price Cut in Off-Year Revision: Jiho Tally
March 9, 2021
-
BUSINESS Takeda Aims for Mid-Teens Annual Growth in Japan Oncology Biz: Exec
March 8, 2021
-
REGULATORY MHLW Presents Views on “Pharma Industry Vision 2021” to LDP’s Project Team
March 8, 2021
-
REGULATORY Japan Confirms 1st Case of Anaphylaxis from COVID-19 Vaccination
March 8, 2021
-
REGULATORY Japan to Review Moderna Vaccine with Top Priority, May OK Possible: Minister
March 8, 2021
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…